Parabolic Drugs Limited reported unaudited earnings results for the fourth quarter and year ended March 31, 2020. For the quarter, the company reported net loss for the period was INR 72.2 million compared to INR 94.3 million a year ago. Total comprehensive loss for the period was INR 72.2 million compared to INR 94.3 million a year ago. Basic loss per share was INR 1.17 compared to INR 1.52 a year ago. Diluted loss per share was INR 1.17 compared to INR 1.40 a year ago. For the year, the company reported total income was INR 0.2 million compared to INR 188.8 million a year ago. Net loss for the period was INR 286.4 million compared to INR 414.0 million a year ago. Total comprehensive loss for the period was INR 286.4 million compared to INR 414.0 million a year ago. Basic loss per share was INR 4.63 compared to INR 6.69 a year ago. Diluted loss per share was INR 4.63 compared to INR 6.69 a year ago.